Celldex Therapeutics, Inc. - CLDX
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | SVP & Chief Commercial Officer | A | A | 90,000.0 | 0.0 | 0.0 | 90,000.0 | View | |
| Jun 29, 2026 | SVP & GENERAL COUNSEL | A | A | 93,000.0 | 0.0 | 0.0 | 93,000.0 | View | |
| Jun 29, 2026 | SVP, CHIEF MEDICAL OFFICER | A | A | 57,000.0 | 0.0 | 0.0 | 57,000.0 | View | |
| Jun 29, 2026 | SVP OF REGULATORY AFFAIRS | A | A | 95,000.0 | 0.0 | 0.0 | 95,000.0 | View | |
| Jun 29, 2026 | SVP AND CFO | A | A | 93,000.0 | 0.0 | 0.0 | 93,000.0 | View | |
| Jun 29, 2026 | SVP OF CORP AFFAIRS & ADMIN. | A | A | 95,000.0 | 0.0 | 0.0 | 95,000.0 | View | |
| Jun 29, 2026 | SR. VP & CPDO | A | A | 100,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jun 29, 2026 | SR. VP & CBO | A | A | 20,000.0 | 0.0 | 0.0 | 20,000.0 | View | |
| Jun 29, 2026 | EXECUTIVE VP & CSO | A | A | 115,000.0 | 0.0 | 0.0 | 115,000.0 | View | |
| Jun 29, 2026 | PRESIDENT & CEO | A | A | 375,000.0 | 0.0 | 0.0 | 375,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View | |
| Jun 29, 2026 | — | A | A | 26,000.0 | 0.0 | 0.0 | 26,000.0 | View |